CompuGroup Medical : Company Presentation June

06|2021

IR PRESENTATION

Dr. Dirk Wössner, CEO

Michael Rauch, CFO

Claudia Thomé, CVP IR

Disclaimer

The information provided in this presentation pertaining to CompuGroup Medical SE & Co. KGaA (the "Company"), comprise the written materials/slides for presentations or discussions on the occasion of an investor conference, meeting or conference call ("Meeting"). Whilst all reasonable care has been taken to ensure that the information and facts stated herein as well as oral statements made in the Meeting are accurate and that the opinions and expectations contained herein and orally received during the Meeting are fair and reasonable, no representation or warranty, express or implied, is given by or on behalf of the Company, any of its board members, or any other person as to the accuracy or completeness of the information and/or opinions and no liability as to the accuracy of such information and/or opinions is accepted. The information provided in this presentation as well as during the Meeting contain forward looking statements which involve risks and uncertainties. These forward-looking statements speak only as of the date of the documents and are based on numerous assumptions which may or may not prove to be correct. The actual performance and results of the business of the Company could differ materially from the performance and results discussed in this document or in any other information received during the Meeting. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements or other information contained herein or received during the Meeting whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Readers are cautioned not to place undue reliance on forward-looking statements or financial projections. The information contained in this presentation and/or received during the Meeting does not constitute or form any part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any shares in the Company, nor shall it or any part of it nor the fact of its distribution form the basis of, or be relied on in connection with, any contract or investment decision in relation thereto.

2

May 2021

IR presentation

CompuGroup Medical - A major beneficiary of digitization in healthcare

Digitization

& Interoperability

along the patient journey

while protecting

medical data and infrastructure

3

May 2021

IR presentation

Servicing the entire healthcare ecosystem, we are ideally positioned for growth

REV SHARE

CUSTOMERS

MARKET POSITIONS

GROWTH

AIS - Ambulatory

Information Systems

45%

Doctors (GPs, specialists), therapists, nurses…

#1	Germany, France,
	Austria, Czech Republic,
	Sweden, Denmark
#2	Italy, Belgium, Norway
#3	Slovakia, Netherlands
#4	USA

		HIS - Hospital		CHS - Consumer &				PCS - Pharmacy
	Information Systems		Health Management			Information Systems
		22%		19%				14%
	Hospitals (acute, post-		All healthcare participants,			Pharmacies
	acute), laboratories		pharma & insurance
				companies, patients
#2	D-A-CH		#1|2	Frontrunner in		#1	Italy
#2	Spain (public hospitals)			Telematics		#4	Germany
		Infrastructure (TI)
#2	Poland
		Sweden
#1

DIGITIZATION & REGULATORY INITIATIVES

DRIVERS (mid-term)

Additional modules &				TI: new user groups &		Additional modules &
	Rollout of G3 platform
functionalities		Hospital Future Act		modules		functionalities
Patient portals &		(Germany)		Data services		G3 rollout
telemedicine (Clickdoc)		P1 project (Poland)		Patient portals
US synergies & scale effects

4

May 2021

IR presentation

Excellent long-term financial track record

			Growth	33%	26%	33%	21%	28%	27%	28%	7%	27%	13%	2%	12%	5%	3%	4%	23%	4%	12%
																					837		CAGR: 17%
														460	515	543	560	582	717	746
										293	312	397	451
						116	140	180	229
			52	69	87
	Revenue in €m
	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020
			Margin
			31%	26%	36%	34%	27%	28%	21%	20%	21%	19%	23%	21%	19%	21%	22%	22%	26%	27%	26%
			CAGR: 16%
													105	98	96	112	126	128	188	198	215
											67	74
					31	40	38	51	49	59
			16	18
	EBITDA in €m
	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020
																			1.95			CAGR: 17%
																			1.74	1.90
					0.22	0.33	0.26	0.46		0.24	0.33		0.62	0.48	0.52	0.77	0.90	0.63
			0.12	0.03	0.03	0.19
	EPS in €
	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020

EBITDA and eps adjusted for 2011, 2014, 2018, 2019, 2020.

5

May 2021

IR presentation